Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Cyclical etidronate in the treatment of postmenopausal osteoporosis: efficacy and safety after seven years of treatment.

Miller PD, Watts NB, Licata AA, Harris ST, Genant HK, Wasnich RD, Ross PD, Jackson RD, Hoseyni MS, Schoenfeld SL, Valent DJ, Chesnut CH 3rd.

Am J Med. 1997 Dec;103(6):468-76. Erratum in: m J Med 1998 Jun;104(6):608.

PMID:
9428829
2.

Etidronate and alendronate in the treatment of postmenopausal osteoporosis.

Beauchesne MF, Miller PF.

Ann Pharmacother. 1999 May;33(5):587-99. Review.

PMID:
10369624
3.

Etridronate therapy in the treatment and prevention of osteoporosis.

Hanley DA, Ioannidis G, Adachi JD.

J Clin Densitom. 2000 Spring;3(1):79-95. Review.

PMID:
10745305
4.
5.

Critical drug appraisal: etidronate intermittent cyclic therapy for postmenopausal osteoporosis.

Miller PD.

Br J Clin Pract. 1996 Jan-Feb;50(1):23-31. Review.

PMID:
8729598
6.

Etidronic acid. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.

Dunn CJ, Fitton A, Sorkin EM.

Drugs Aging. 1994 Dec;5(6):446-74. Review.

PMID:
7858370
7.

[Etidronate].

Inui K, Takaoka K.

Nihon Rinsho. 2003 Feb;61(2):226-30. Review. Japanese.

PMID:
12638212
8.

Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.

Wells GA, Cranney A, Peterson J, Boucher M, Shea B, Robinson V, Coyle D, Tugwell P.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD003376. doi: 10.1002/14651858.CD003376.pub3. Review.

PMID:
18254018
9.

Long-term tolerability of the bisphosphonates in postmenopausal osteoporosis: a comparative review.

Kherani RB, Papaioannou A, Adachi JD.

Drug Saf. 2002;25(11):781-90. Review.

PMID:
12222989
10.

WITHDRAWN: Etidronate for treating and preventing postmenopausal osteoporosis.

Cranney A, Adachi JD, Griffith L, Guyatt G, Krolicki N, Robinson VA, Shea BJ, Wells G.

Cochrane Database Syst Rev. 2007 Jul 18;(1):CD003376. Review.

PMID:
17636719
11.

Etidronate for treating and preventing postmenopausal osteoporosis.

Cranney A, Welch V, Adachi JD, Guyatt G, Krolicki N, Griffith L, Shea B, Tugwell P, Wells G.

Cochrane Database Syst Rev. 2001;(4):CD003376. Review. Update in: Cochrane Database Syst Rev. 2006;(1):CD003376. Cochrane Database Syst Rev. 2008;(1):CD003376.

PMID:
11687195
12.

Didronel PMO.

Stone M.

Br J Hosp Med. 1993 Feb 17-Mar 2;49(4):275-7. Review.

PMID:
8443628
13.

[Indications and limitations of non-hormonal treatments of osteoporosis].

Avouac B.

Rev Fr Gynecol Obstet. 1993 Jul-Sep;88(7-9):419-23. Review. French.

PMID:
8235256
14.

[Etidronate for treatment of osteoporosis].

Asano S, Suzuki A, Itoh M.

Nihon Rinsho. 2009 May;67(5):938-42. Review. Japanese.

PMID:
19432113
16.

Treatment of postmenopausal osteoporosis with etidronate.

Heyneman CA.

Ann Pharmacother. 1993 Oct;27(10):1200-1. Review. No abstract available.

PMID:
8251688
17.

Clodronate and osteoporosis.

Kanis JA, McCloskey EV, Beneton MN.

Maturitas. 1996 May;23 Suppl:S81-6. Review.

PMID:
8865146
18.

[Therapy of osteoporosis using the ADFR schedule (especially with parathyroid hormone and etidronate)].

Ziegler R.

Internist (Berl). 1991 Feb;32(2):76-9. Review. German. No abstract available.

PMID:
1903362
19.

Efficacy of oral etidronate for skeletal diseases in Japan.

Iwamoto J, Takeda T, Sato Y.

Yonsei Med J. 2005 Jun 30;46(3):313-20. Review.

20.

Etidronate for vertebral osteoporosis after the menopause.

[No authors listed]

Drug Ther Bull. 1992 Jun 8;30(12):45-6. Review. No abstract available.

PMID:
1623814
Items per page

Supplemental Content

Write to the Help Desk